The mosquitoes of Finland: updated distributions and bionomics.

Mosquitoes (Diptera: Culicidae) were collected in Finland between 2012 and 2018 to determine the species present and their distributions. In total, 52 466 specimens from 1031 collections formed the basis for the preparation of distribution maps for each of the 40 species that were collected. Anopheles maculipennis s.s., An. claviger, Aedes geminus and Ochlerotatus sticticus are confirmed on mainland Finland after previous records were uncertain or absent. Coquillettidia richiardii, Culiseta morsitans, Cs. ochroptera, Culex territans, Cx. torrentium, Oc. leucomelas, Oc. nigrinus, Oc. pullatus and Oc. punctodes occur more widely than previously reported. Three species, Ae. rossicus, Cs. subochrea and Oc. cyprius were not collected, although Ae. rossicus was subsequently found in Lapland by another researcher. No invasive species were collected. Ochlerotatus communis, an aggressive biter, was the most commonly encountered species. Larval collection data suggest that several species may have up to three generations per year in Finland, with Cx. torrentium and Cx. pipiens having at least two, and Oc. communis and Oc. punctor regularly found as larvae across the summer. These data, especially when coupled with historical records, are vital for monitoring species which have significant vector potential, particularly when faced with a warming climate.

Phosphorus mitigation during springtime runoff by amendments applied to grassed soil.

Permanent grass vegetation on sloping soils is an option to protect fields from erosion, but decaying grass may liberate considerable amounts of dissolved reactive P (DRP) in springtime runoff. We studied the effects of freezing and thawing of grassed soil on surface runoff P concentrations by indoor rainfall simulations and tested whether the peak P concentrations could be reduced by amending the soil with P-binding materials containing Ca or Fe. Forty grass-vegetated soil blocks (surface area 0.045 m, depth 0.07 m) were retrieved from two permanent buffer zones on a clay and loam soil in southwest Finland. Four replicates were amended with either: (i) gypsum from phosphoric acid processing (CaSO × 2HO, 6 t ha), (ii) chalk powder (CaCO, 3.3 t ha), (iii) Fe-gypsum (6 t ha) from TiO processing, or (iv) granulated ferric sulfate (Fe[SO], 0.7 t ha), with four replicates serving as untreated controls. Rainfall (3.3 h × 5 mm h) was applied on presaturated samples set at a slope of 5% and the surface runoff was analyzed for DRP, total dissolved P (TDP), total P (TP), and suspended solids. Rainfall simulation was repeated twice after the samples were frozen. Freezing and thawing of the samples increased the surface runoff DRP concentration of the control treatment from 0.19 to 0.46 mg L, up to 2.6-3.7 mg L, with DRP being the main P form in surface runoff. Compared with the controls, surface runoff from soils amended with Fe compounds had 57 to 80% and 47 to 72% lower concentrations of DRP and TP, respectively, but the gypsum and chalk powder did not affect the P concentrations. Thus, amendments containing Fe might be an option to improve DRP retention in, e.g., buffer zones.

Posterior capsular opacification in pseudophakic eyes with a silicone or acrylic intraocular lens.

PURPOSE: To compare posterior capsular opacification in eyes with IOL of two different materials--silicone or acrylic. METHODS: Eighty consecutive eyes undergoing cataract surgery were prospectively randomized in two groups, 40 eyes receiving a silicone (Sl--30NB) and 40 eyes an acrylic (Acrysof MA60BM) intraocular lens (IOL). The same surgeon performed phacoemulsification and the intraocular lens (PHACO IOL) operation in all cases. Patients were re-examined on the first postoperative day, after one week, four months, and 1-2.4 years. Seven eyes were lost to late control. RESULTS: Clinically significant posterior capsular opacification (PCO) (including eyes with capsulotomy already performed) was equally common in both groups; 25% in the silicone group and 19% in the acrylic group (p=0.53). The posterior capsule remained clear in 61% of the silicone and 76% of the acrylic IOL eyes (p=0.18). In the whole study group, 29% of eyes with and 14% without concurrent ocular diseases had significant PCO (p=0.13). In the silicone IOL group, PCO was more common in eyes with concurrent ocular diseases (44%) than eyes without other diseases (10%) (p=0.049). Eyes with acrylic IOL showed no difference in significant PCO, with or without other diseases (18% and 20%, respectively). CONCLUSIONS: In a consecutive series of 80 cataract eyes central PCO was equally common in eyes receiving a silicone or an acrylic IOL. In the silicone IOL group, however, significant PCO was more common if there was concurrent ocular disease, while with the acrylic IOL concurrent ocular disease did not seem to increase the risk of PCO.

Topical anesthesia with or without propofol sedation versus retrobulbar/peribulbar anesthesia for cataract extraction: prospective randomized trial.

PURPOSE: To evaluate the feasibility of intravenous sedation in addition to topical anesthesia during cataract extraction. SETTING: Helsinki University Eye Hospital, Helsinki, Finland. METHODS: Three hundred seventeen eyes of 291 consecutive patients having cataract surgery were prospectively randomized to receive topical (oxybuprocaine 0.4%, n = 96), combined (topical anesthesia and propofol sedation, n = 107), or retrobulbar/peribulbar (prilocaine 1.5%, n = 114) anesthesia. The intraoperative conditions were judged by the surgeon. A numerical scale (0 to 10) was used to assess the degree of pain during surgery. Outcome measures were the number of complications and adverse events registered perioperatively and 1 week postoperatively as well as Snellen visual acuity. RESULTS: The success of posterior chamber intraocular lens (IOL) implantation through a self-sealing clear corneal incision was 97.9%, 96.3%, and 98.2% in the topical, combined, and retrobulbar/peribulbar groups, respectively. There was no difference among the groups in pain during surgery, frequency of complications, or outcome measures. One week postoperatively, visual acuity was 20/40 or better in 81.7%, 78.5%, and 77.5% of eyes in the topical, combined, and retrobulbar/peribulbar groups, respectively. The surgeon reported significantly fewer difficulties in the retrobulbar/peribulbar group (9.8%) than in the topical (26.0%) (P =.004) or combined (21.0%) (P =.036) groups. Additional sedative/analgesic medication given intraoperatively was required significantly more often in the topical (15.6%) than in the retrobulbar/peribulbar group (2.6%) (P =.002). Patients with bilateral surgery preferred combined anesthesia over retrobulbar/peribulbar anesthesia; however, there was no significant difference in patient acceptance among groups in patients having unilateral surgery. CONCLUSION: Intravenous propofol sedation added to topical anesthesia did not improve the operative conditions or surgical outcome. Retrobulbar/peribulbar anesthesia ensured the best surgical conditions. Patients in all anesthesia groups reported high satisfaction. However, patients having bilateral surgery seemed to prefer combined anesthesia over retrobulbar/peribulbar anesthesia.

Phacoemulsification and intraocular lens implantation in eyes with open-angle glaucoma.

PURPOSE: To study the effect of phacoemulsification and intraocular lens implantation (PHACO IOL) on intraocular pressure (IOP) and glaucoma medication in open-angle glaucoma (OAG) eyes. METHODS: 38 open-angle glaucoma (OAG) eyes with cataract underwent phacoemulsification and intraocular lens implantation (PHACO IOL) performed by one surgeon (RJU). None of the patients had prior intraocular surgery. Surgery was performed by scleral incision on 37% and by clear corneal incision on 63%. Patients were re-examined on the first postoperative day, after one week, 4 months, and in 29 cases 1-3.7 (mean 2.8) years after the operation. RESULTS: The mean preoperative IOP was 18.4+/-3.3 mmHg with a mean of 1.7 glaucoma medications. On the first postoperative day, the mean IOP rose to 28.2 +/- 12.5 mmHg. IOP > or = 30 mmHg occurred in 39.5% of the eyes. After one week, IOP had returned to the preoperative level. After 4 months, IOP had further decreased to 16.1 +/- 3.8 mmHg (p = 0.0027). After a mean follow-up of 1-3.7 (mean 2.8) years, the average postoperative IOP was 15.1 +/- 2.9 mmHg, being significantly (p = 0.001) lower than the preoperative IOP with 86% of the patients having a mean of 1.6 drugs on average. The type of incision (scleral vs. corneal) did not affect the postoperative IOP level. Using the criteria of Bigger and Becker (1971) the long-term IOP control after PHACO-IOL surgery was improved or unchanged in 86% and worse in 14% of the preoperatively well-controlled OAG eyes. CONCLUSIONS: In OAG eyes PHACO IOL is associated with a significant decrease in IOP with less medication up to 1-3.7 (mean 2.8) years.

Particulate phosphorus and sediment in surface runoff and drainflow from clayey soils.

Recent work has shown that a significant portion of the total loss of phosphorus (P) from agricultural soils may occur via subsurface drainflow. The aim of this study was to compare the concentrations of different P forms in surface and subsurface runoff, and to assess the potential algal availability of particulate phosphorus (PP) in runoff waters. The material consisted of 91 water-sample pairs (surface runoff vs. subsurface drainage waters) from two artificially drained clayey soils (a Typic Cryaquept and an Aeric Cryaquept) and was analyzed for total suspended solids (TSS), total phosphorus (TP), dissolved molybdate-reactive phosphorus (DRP), and anion exchange resin-extractable phosphorus (AER-P). On the basis of these determinations, we calculated the concentrations of PP, desorbable particulate phosphorus (PPi), and particulate unavailable (nondesorbable) phosphorus (PUP). Some water samples and the soils were also analyzed for 137Cs activity and particle-size distribution. The major P fraction in the waters studied was PP and, on average, only 7% of it was desorbable by AER. However, a mean of 47% of potentially bioavailable P (AER-P) consisted of PPi. The suspended soil material carried by drainflow contained as much PPi (47-79 mg kg-1) as did the surface runoff sediment (45-82 mg kg-1). The runoff sediments were enriched in clay-sized particles and 137Cs by a factor of about two relative to the surface soils. Our results show that desorbable PP derived from topsoil may be as important a contributor to potentially algal-available P as DRP in both surface and subsurface runoff from clayey soils.

Intraocular pressure after phacoemulsification and intraocular lens implantation in nonglaucomatous eyes with and without exfoliation.

PURPOSE: To evaluate intraocular pressure (IOP) after phacoemulsification and intraocular lens (IOL) implantation in nonglaucomatous eyes with and without exfoliation. SETTING: Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland. METHODS: One hundred ninety-six eyes that had phacoemulsification with IOL implantation were examined. Eyes with a history of intraocular disease or surgery that could affect IOP were excluded. The study comprised the remaining 160 eyes: 23 with exfoliation (EXF group) and 137 without exfoliation (non-EXF group). Follow-up data were available for 136 eyes. The same surgeon performed all surgeries. Patients were examined on the first postoperative day and after 1 week, 4 months, and 1.0 to 2.7 years. RESULTS: One day postoperatively, IOP rose in the EXF group from a mean preoperative level of 16.3 mm Hg +/- 2.7 (SD) to 21.0 +/- 8.5 mm Hg, a 28.4% increase (P =.0061). In the non-EXF group, mean IOP rose from 16.2 +/- 3.4 mm Hg to 20.5 +/- 5.7 mm Hg, a 29.9% increase (P =.001). In 4 eyes (17.4%) in the EXF group and 8 eyes (5.8%) in the non-EXF group, IOP increased to 30 mm Hg or higher at 1 day. After this, significant IOP decreases occurred in both the EXF and non-EXF group, respectively, as follows: 14.2 +/- 3.0 mm Hg (12.0% decrease from preoperative value; P =.001) and 15.0 +/- 2.9 mm Hg (5.9%; P =.001) 1 week postoperatively; 12.8 +/- 2.7 mm Hg (20.2%; P =.0002) and 13.8 +/- 2.7 mm Hg (13.2%; P =.001) after 4 months; and 12.3 +/- 2.6 mm Hg (23.2%; P =.0001) and 12.7 +/- 2.7 mm Hg (21.2%; P =.001) after 1.0 to 2.7 years. There was no significant difference between the 2 groups. CONCLUSION: After phacoemulsification with IOL implantation, IOP decreased significantly and remained lower than preoperatively in eyes with and without exfoliation. One day postoperatively, transient pressure peaks were more common in eyes with exfoliation. One eye without exfoliation developed glaucoma.

Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma.

This study was an attempt to compensate for an alleged aetiological deficiency in melanoma by the prophylactic oral administration of the essential biological components missing. Nine random patients suffering from high-risk uveal melanoma (T3) were, in this preliminary study, treated secondarily with biological dietary adjuvants after primary standard therapy, enucleation or brachytherapy. Secondary treatment consisted of certain natural amino-acids, trace-element salts, folic acid and a diet containing neurogenic lipid components. It entailed no side-effects, no toxicity and was inexpensive. None of these nine patients has suffered recurrent disease. The mean follow-up time was over 80 months (median 69, range 58-140 months). Local tumour control was 100%. This clinical result is significantly better (p = 0.018) as compared to similar T3 uveal melanoma patients in standard care who did not receive adjuvant dietary remedies after primary treatment. The control patients consisted of similar adjusted T3 cases selected from the Swedish official registries, and T2 patients from Germany. Based on the previous positive clinical results obtained with cutaneous malignant melanoma in bioimmunotherapy this additional positive result supports the notion that biological components administered orally may compensate for the etiological deficiency leading to malignant melanoma.

Potentiation in the first visual synapse of the fly compound eye.

In the first visual synapse of the insect compound eye, both the presynaptic and postsynaptic signals are graded, nonspiking changes in membrane voltage. The synapse exhibits tonic transmitter release (even in dark) and strong adaptation to long-lasting light backgrounds, leading to changes also in the dynamics of signal transmission. We have studied these adaptational properties of the first visual synapse of the blowfly Calliphora vicina. Investigations were done in situ by intracellular recordings from the presynaptic photoreceptors, photoreceptor axon terminals, and the postsynaptic first order visual interneurons (LMCs). The dark recovery, the shifts in intensity dependence, and the underlying processes were studied by stimulating the visual system with various adapting stimuli while observing the recovery (i.e., dark adaptation). The findings show a transient potentiation in the postsynaptic responses after intense light adaptation, and the underlying mechanisms seem to be the changes in the equilibrium potential of the transmitter-gated conductance (chloride) of the postsynaptic neurons. The potentiation by itself serves as a mechanism that after light adaptation rapidly recovers the sensitivity loss of the visual system. However, this kind of mechanism, being an intrinsic property of graded potential transmission, may be quite widespread among graded synapses, and the phenomenon demonstrates that functional plasticity is also a property of graded synaptic transmission.

Evaluating cataract surgery gains by assessing patients' quality of life using the VF-7.

PURPOSE: To describe the development and performance of a questionnaire designed to measure functional impairment caused by cataract. SETTING: Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland. METHODS: The results of a visual-functioning index (VF-14) of 168 patients with first-eye cataract surgery were analyzed. Patients with significant comorbidity were excluded, leaving 142 patients for the final analysis. Snellen visual acuity measurements and complete preoperative and 4 month postoperative clinical status were performed by ophthalmologists. Outcome measures, including the VF-14, patient perception of trouble with vision, patient satisfaction with vision, and the cataract symptom score, were taken by nurses at the preoperative clinical examinations and at the 4 month postoperative visit. The Spearman rank correlation was used to determine which items of the VF-14 best correlated with a change in patient satisfaction. RESULTS: Seven items of the VF-14 that best correlated with patient satisfaction were selected for inclusion in a new 7-item index (the VF-7). Based on the Spearman rank correlation, the items from best to worst were nighttime driving; reading small print; watching television; seeing steps, stairs, or curbs; reading traffic, street, or store signs; cooking; and doing fine handwork. The correlation among changes in the VF-7 score and visual acuity in the operated eye was 0.17, while the correlation among changes in the VF-7 and patient satisfaction caused by cataract surgery was high (r = .56). CONCLUSION: The VF-7 was a strong predictor of change in patient satisfaction caused by cataract surgery.

Converting to topical anesthesia in cataract surgery.

PURPOSE: To evaluate the complications and difficulties encountered by surgeons converting from paraocular to topical anesthesia in cataract surgery and to evaluate patient pain and satisfaction with each procedure. SETTING: Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland. METHODS: Three hundred eyes of 245 consecutive patients were prospectively assigned by permuted block-restricted randomization to receive topical (bupivacaine 0.75%) (Group 1; n = 136) or paraocular (Group 2; n = 163) anesthesia. The intraoperative conditions were judged by the surgeon. A numerical scale (0 to 10) was used to assess the degree of pain during administration of anesthesia, during surgery, and 1 and 24 hours postoperatively. Outcome measures were the number of complications and adverse events registered perioperatively and 4 months postoperatively as well as Snellen visual acuity and surgically induced astigmatism (SIA) measured 1 week and 4 months after surgery. RESULTS: The success of posterior chamber intraocular lens (IOL) implantation through a self-sealing clear corneal incision was very high (99.3% and 96.9% in Groups 1 and 2, respectively). One case (0.7%) in the topical group required vitrectomy and implantation of an anterior chamber IOL. Anesthesia-related difficulties were reported in about 40% of patients in Group 1 and 4% in Group 2 (P < .001). Supplemental paraocular anesthesia was required in 4 cases (2.9%) in the topical group. Sedative/analgesic medication given perioperatively was required significantly more often in Group 1 (13.2%) than in Group 2 (2.4%) (P < .01). Significantly more pain during surgery (P < .001) and 1 hour after surgery (P < .001) was reported in the topical group. In Group 1 69.9% and in Group 2 93.3% reported no pain during surgery (P < .001). Chemosis (1.8%), subconjunctival hemorrhage (1.2%), and periorbital hematoma (1.2%) were seen only in the paraocular group. Perioperatively, no severe complications occurred in Group 1 and the number of adverse events was less than in Group 2. Postoperatively, 2 cases of endophthalmitis developed in the topical group and none in the paraocular group. There was no between-group difference in outcome measures; a visual acuity of 20/40 or better was found in 87.8% of eyes in Group 1 and 84.9% in Group 2 4 months postoperatively, and the percentages of eyes with SIAs within 1.0 diopter of preoperative values were similar (78.6% and 73.3%, respectively). Patient preference for topical anesthesia appeared to be higher than for paraocular anesthesia. CONCLUSION: Paraocular anesthesia gave better analgesia than topical, but topical anesthesia provided acceptable analgesia during surgery and showed that intraocular procedures can be performed without akinesia. The surgeon converting to topical anesthesia may expect slight difficulty in 40% of cases and more severe difficulty in 7%. Surgically related complications were similar with both methods.

Outcomes of small incision cataract surgery.

PURPOSE: To compare cataract surgery outcome measures 4 months postoperatively and determine their association with changes in the eye's functional state. SETTING: Department of Ophthalmology, Helsinki University Central Hospital, Finland. METHODS: This longitudinal study comprised 219 consecutive patients having first-eye or second-eye cataract surgery by one surgeon. In most patients, the technique consisted of small-incision cataract surgery with in-the-bag intraocular lens implantation. Patients were interviewed and clinical data obtained preoperatively and 4 months postoperatively. Adverse events occurring within 24 hours and 4 months postoperatively were compared with changes in global measures of vision. Surgical success in terms of surgically induced astigmatism (SIA) was measured at 4 months using vector analysis of the changes in astigmatism and defining the extent to which the surgical goal was achieved. The association between the surgical astigmatism goals and global measures of vision was analyzed. RESULTS: The percentage of patients showing improvement 4 months after first-eye cataract surgery varied by outcome measure: Snellen visual acuity (95.0%), VF-14 score (89.4%), satisfaction with vision (80.1%), self-reported trouble with vision (75.8%), and cataract symptoms (75.1%). Changes in Snellen acuity after second-eye cataract surgery were similar but VF-14 changes were significantly less than after first-eye surgery. Changes in global measures of vision were also better after first-eye surgery. The correlation between the change in VF-14 score and global measures of vision was stronger than between the change in Snellen acuity and the same general outcome measures. A good correlation was also seen between the changes in VF-14 scores and cataract symptoms. Mean SIA in all eyes was 0.2 diopter (D) +/- 0.7 (SD); 91.2% were within +/- 1.0 D of preoperative values. Failure to achieve surgical astigmatism goals was not associated with patients in whom global measures of vision did not improve, nor was there a correlation between adverse events occurring within 24 hours or 4 months postoperatively and global measures of vision. The only association was between ocular comorbidity or potential risk factors of phacoemulsification and adverse events seen within 24 hours and at 4 months. CONCLUSION: Estimates of the proportion of patients benefiting from cataract surgery varied with the outcome measure used to determine benefit. The change in the VF-14 score was a better measure than Snellen acuity of the benefit of cataract surgery.

Lectin binding in normal, scarred, and keratoconus corneas.

PURPOSE: Keratoconus is characterized by central thinning and an increased curvature of cornea. Scarring of cornea accompanies the disease as it proceeds, and the ultimate treatment is keratoplasty. The pathogenesis of keratoconus is still unknown, and therefore we studied normal, keratoconus, and scarred corneas by a panel of lectin conjugates. METHODS: The following lectin conjugates were used: concanavalin A (Con A), Dolichos biflorus agglutinin (DBA), peanut agglutinin (PNA), Ulex europaeus agglutinin (UEA-I), wheat-germ agglutinin (WGA), Helix aspersa agglutinin (HAA), Psophocarpus tetragonolobus agglutinin (PTA), soybean agglutinin (SBA), Griffonia simplicifolia agglutinin-I-B4 (GSA-I-B4), Ricinus communis agglutinin (RCA-I), and Lotus tetragonolobus agglutin (LTA) conjugates, differently recognizing saccharide residues in glycoconjugates. RESULTS: One of the keratoconus corneas was badly scarred, whereas no scars were seen on histopathologic examination in other keratoconus corneas. In all keratoconus corneas, discontinuities or breaks (defects) were seen in the Bowman's layer. DBA and HAA conjugates, both blood group A reactive, reacted with corneal and conjunctival epithelium, blood vessels, and endothelium in blood groups A and AB. The blood group B-reactive GSA-I-B4 conjugate reacted with corneal and conjunctival epithelium, blood vessels, and endothelium only in specimens with blood group B. The blood group O-reactive UEA-I conjugate revealed the apical epithelial cells and blood vessels in all blood groups, whereas LTA conjugate, also blood group O reactive, reacted with all structures in cornea and conjunctiva despite blood groups. HAA and DBA conjugates reacted with defects in keratoconus corneas, SBA and RCA-I conjugates with defect area in keratoconus and scar region in scarred corneas, and PNA and WGA conjugates with the scar region of scarred keratoconus and scarred corneas. No other differences in the binding of lectins between normal, scarred, and keratoconus corneas were seen. CONCLUSIONS: The results indicate that the blood group status influences lectin binding in cornea. Furthermore, the difference in lectin binding to defects in keratoconus corneas (HAA and DBA conjugates) and to scar regions in scarred corneas (PNA and WGA conjugates) suggests that the defects in keratoconus are not solely the results of scarring.

Cellular and plasma fibronectin in the aqueous humour of primary open-angle glaucoma, exfoliative glaucoma and cataract patients.

PURPOSE: To compare the concentrations of cellular fibronectin (cFN), plasma fibronectin (pFN), tenascin and calcitonin gene-related peptide (CGRP) in the aqueous humour in primary open-angle glaucoma (POAG), exfoliative glaucoma (EXFG) or cataract (control group). METHODS: The concentrations were determined by enzyme-linked immunoassays in the aqueous humour of patients with EXFG (n = 26), POAG (n = 29) or cataract (control group, n = 13). RESULTS: The pFN concentrations of the three patient groups differed significantly from each other (p = 0.0004 in a non-parametric analysis of variance). In multiple comparisons EXFG patients showed significantly higher pFN levels than POAG patients (p < 0.05) or cataract patients (p < 0.01). the cFN level was also significantly higher in EXGF patients than in POAG patients (p < 0.05) or cataract patients (p < 0.05). The pFN or cFN concentrations of the POAG group did not differ from those of the control group. Neither tenascin nor CGRP was detected in the aqueous humour of any of our patients. CONCLUSIONS: The significantly higher aqueous humour pFN concentration in exfoliative glaucoma may be a consequence of disruption of the blood-aqueous barrier and may further add to an increased outflow resistance.

Traumatic aphakia treated with an iris prosthesis/intraocular lens or epikeratophakia.

OBJECTIVE: We retrospectively analyzed the visual results and postoperative complications associated with severely traumatized eyes in which aphakia was corrected with epikeratophakia or a sutured iris prosthesis/intraocular lens (IOL). METHODS: Fourteen eyes (14 patients) with traumatic aphakia and severe anterior segment complications were corrected either with epikeratophakia or a sutured iris prosthesis/IOL. All eyes lacked lens capsule or iris support for an IOL. The surgical technique of implanting an iris prosthesis/IOL employed transcleral suturing in the ciliary sulcus combined with penetrating keratoplasty. RESULTS: In the eight eyes treated with epikeratophakia, four (50%) had spectacle-corrected visual acuity of 20/40 or better. Almost all of these eyes lost one or two Snellen lines of baseline spectacle-corrected visual acuity. Few complications occurred after epikeratophakia; none were severe. Of six eyes with penetrating keratoplasty and a sutured iris prosthesis/IOL or a sutured posterior chamber IOL, two (33%) achieved a visual acuity of 20/40 or better. In the IOL group, severe complications occurred, including posterior dislocation of the lens and secondary glaucoma. CONCLUSIONS: The surgical correction of aphakia in severely traumatized eyes requires specialized surgical techniques. Epikeratophakia is a low-risk operation that can be performed in eyes in which an IOL is contraindicated. The iris prosthesis/IOL technique results in good cosmetic results; however, due to complications, this technique should be used with caution.

Compatibility of corticosteroids and antibiotics in combination.

PURPOSE: To study the compatibility of combinations of antibiotics and steroids commonly used in anterior segment surgery. SETTING: Research Laboratory, Helsinki University, Finland. METHODS: Aggregate production in vitro and in vivo was studied for three injectable antibiotics (cefotaxime sodium, tobramycin sulfate, and gentamicin) and four corticosteroids (triamcinolone acetonide, methylprednisolone sodium succinate, methylprednisolone acetate, and dexamethasone sodium phosphate) using conventional and dark-field microscopy. Aggregate formation on collagen shields and subconjunctival aggregate formation of tobramycin sulfate in combination with methylprednisolone acetate or dexamethasone sodium phosphate was also studied. RESULTS: Dexamethasone sodium phosphate (4 mg/mL) did not form aggregates with any of the three antibiotics tested. Cefotaxime sodium did not cause aggregates when 24 mg/mL of dexamethasone sodium phosphate was used both in vitro and in vivo or in association with collagen shields. CONCLUSIONS: To avoid undesired side effects, such as epithelial sloughing and corneal edema after collagen shield application, antibiotics and steroids must be carefully selected.

Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.

The aim of this work was to compare the efficacy of cyclosporine (CsA) collagen shields and fragments in suppressing experimental allograft rejection in an animal model for high risk keratoplasty. Altogether 23 experimental animals were treated either with plain collagen shields, oral cyclosporine, collagen CsA shields, or with CsA collagen fragments after corneal transplantation (PKP) in previously vascularized corneas. The study medications were started immediately following PKP. For these animals slit lamp examinations were performed twice a week for the duration of the experiment and the signs of corneal rejection were observed. The animals were followed until an irreversible rejection or until the end of the experiment (14-149 days). The inflammation of the graft was also evaluated histologically when animals were sacrificed. The grafts treated with plain collagen shields all were rejected within 36 days, and the mean graft survival time for these corneas was 25 days. Five transplants that were treated with oral CsA had better survival, and two of five grafts stayed clear until postoperative day 119, when the treatment was stopped. The best graft survival was seen in grafts treated with CsA collagen fragments and all these stayed clear up to 77 days postoperatively. The treatment of the grafts with CsA collagen shields was almost as effective as with CsA fragments, and first signs of rejection appeared as late as nine weeks postoperatively in two of seven grafts. The other of these rejected corneas were later treated with CsA collagen fragments and showed a dramatic improvement in transparency of the cornea and disappearance of inflammation of the graft. The discontinuation of study medication caused an irreversible rejection to appear in a previously clear graft that had been treated successfully with any study medication. We conclude that topical CsA in shields or in fragments will provide a significant advance over systemic CsA alone, and that CsA fragments appear to be as effective as shields in preventing corneal allograft rejection.

Photoastigmatic keratectomy for correction of astigmatism in corneal grafts.

BACKGROUND: The efficacy and safety of excimer laser photoastigmatic refractive keratectomy (PARK) for treatment of astigmatism after penetrating keratoplasty (PKP) was evaluated in this study. METHODS: A VisX 20/20 excimer laser was used to correct the regular astigmatic component of the grafts. The epithelium was removed manually in seven cases and in three patients with the PTK mode of the laser. The results were analyzed for uncorrected visual acuity (UCVA), best corrected acuity (BCVA), haze, and changes in the cylinder and axis. The vectorial change in astigmatism was measured using Alpins' method. RESULTS: Preoperative astigmatism ranged from 3.50 to 11.25 D (mean, 5.98 +/- 2.28) and the mean attempted correction of astigmatism was 6.28 +/- 1.56 D (range, 3.50-9.00 D). The induced reduction of net corneal astigmatism was 48.1%. The vector-corrected astigmatism, which was 6.40 +/- 3.49 D at 1 month postoperatively, was reduced at 12 months to 4.28 +/- 2.42 D. The Alpin Success Index varied in the range 0.06 to 1.0. Although the UCVA improved by > or = 2 lines in 60% of the eyes, the BCVA decreased in 40% of the eyes and three patients required a reoperation. CONCLUSION: Although PARK is relatively safe and effective in reducing post-PKP cylinder and improves UCVA, the frequently and surprisingly late-developing corneal haze often impairs the BCVA.

Long-term follow-up of pediatric epikeratophakia.

BACKGROUND: Epikeratophakia is a potentially reversible corneal surgical procedure that can correct refractive errors in children who are aphakic and poor candidates for intraocular lens implantation. The correction of aphakia in the pediatric population poses specific problems because of associated amblyopia. METHODS: The clinical records of 61 consecutive patients (82 eyes) treated for pediatric aphakia by epikeratophakia were reviewed retrospectively with a follow-up of 3 to 5 years. For the purpose of analysis, the patients were divided into seven groups. RESULTS: The overall success rate for epikeratophakia was 92%, but with repeated surgery, the patient success rate was 93%. The average refractive error at 1 year was + 0.10 diopters (D). At 1 year, 68% of eyes had a refraction within 1 D of emmetropia. In these growing eyes, we documented an average myopic shift of -0.40 D during 4 years. A myopic shift occurred in 30.2% and a hyperopic shift in 9.4% of eyes. Spectacle-corrected visual acuity at 3 years showed 36% of eyes seeing 20/40 or better. Visual acuity results in different groups varied with the timing of epikeratophakia, density of amblyopia and parents' ability to maintain the patching schedule. The most encouraging results came from the treatment of monocular traumatic cataracts. In this group, 31% achieved visual acuities of 20/40 or better and 85% achieved 20/100 or better at final examination. Those with incomplete congenital cataracts also showed favorable results: 39% achieved 20/40 or better at final examination. CONCLUSIONS: Follow-up of 3 to 5 years demonstrated that epikeratophakia can correct refractive errors safely and successfully in aphakic children, either as a primary procedure, or as a secondary procedure after cataract extraction.